Cargando…

Editorial: Thyroid cancer: New perspectives in diagnosis and therapy

Detalles Bibliográficos
Autores principales:	Sarkar, Rhitajit, Lee, Stephanie L., Kumar, Viksit, Thakur, Shilpa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660236/ https://www.ncbi.nlm.nih.gov/pubmed/36386151 http://dx.doi.org/10.3389/fphar.2022.1057731

Ejemplares similares

Editorial: Molecular and multi-omic approaches in understanding cancer biology and anticancer therapies: current perspectives and new challenges
por: Abdel-Wahab, Basel A., et al.
Publicado: (2023)

Editorial: Phytochemicals in cancer prevention and therapeutics: Current advancement and future perspective
por: Pore, Subrata Kumar, et al.
Publicado: (2023)

Editorial: New Therapies in the Field of Rheumatology
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2020)

Editorial: Nutraceuticals: New perspectives and approaches in human health and disease
por: Rosa, Luigi, et al.
Publicado: (2022)

Editorial: Advancing Genomics for Rare Disease Diagnosis and Therapy Development
por: Liu, Zhichao, et al.
Publicado: (2020)

Editorial: Functional Nanomaterials in Inflammatory Diseases: From Prevention to Diagnosis and Therapy
por: Evans, Colin E., et al.
Publicado: (2021)

Editorial: Targeting autophagy in Cancer Therapy: Focus on small-molecule modulators and new strategies
por: Pluta, Ryszard
Publicado: (2023)

A perspective on oligonucleotide therapy: Approaches to patient customization
por: Thakur, Shikha, et al.
Publicado: (2022)

Editorial: Drug development of herbal medicines: Regulatory perspectives
por: Bilia, Anna Rita, et al.
Publicado: (2022)

Editorial: Perspectives of Antiarrhythmic Drug Therapy: Disappointing Past, Current Efforts, and Faint Hopes
por: Nánási, Péter P., et al.
Publicado: (2020)

A new molecular subclassification and in silico predictions for diagnosis and prognosis of papillary thyroid cancer by alternative splicing profile
por: Li, Haiyan, et al.
Publicado: (2023)

Editorial: Emerging perspectives in sodium channelopathies
por: Groome, J. R., et al.
Publicado: (2022)

Editorial: Chemo-Radiation-Resistance in Cancer Therapy
por: Lin, Xiaoping, et al.
Publicado: (2022)

Editorial: Adaptive immune resistance in cancer therapy
por: Jiang, Aimin, et al.
Publicado: (2023)

Editorial: Epigenetic regulation and therapy resistance in cancer
por: Zhu, Yongxia, et al.
Publicado: (2023)

Editorial: New Technologies in Cancer Diagnostics and Therapeutics
por: Li, Haichang, et al.
Publicado: (2021)

Editorial: The roles of immune cell homeostasis in cancer research and therapeutic response
por: Zhang, Kui, et al.
Publicado: (2023)

Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives
por: Roseman, Leor, et al.
Publicado: (2022)

Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics
por: Chandrasekaran, Balakumar, et al.
Publicado: (2023)

Editorial: Novel small molecules in targeted cancer therapy
por: Li, Rong, et al.
Publicado: (2023)

Editorial: New mechanistic insights into cancer precision medicine
por: Kwok, Hang Fai
Publicado: (2023)

Editorial: Prevention, diagnosis and treatment of rare disorders
por: Cox, Timothy M., et al.
Publicado: (2022)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
por: Nishimura, Yuhei, et al.
Publicado: (2018)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

Editorial: Nanoparticles in Cancer Therapy-Novel Concepts, Mechanisms, and Applications
por: Mu, Qingxin, et al.
Publicado: (2019)

Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer
por: Liu, Qi, et al.
Publicado: (2022)

Editorial: Mitochondrial therapy in neurodegeneration
por: Kalani, Anuradha, et al.
Publicado: (2023)

Editorial: The roles of ion-induced cell death in cancer treatment: volume II
por: Zhang, Kui, et al.
Publicado: (2023)

Editorial: Therapeutic targeting of splicing variants in cancer
por: Sarvari, Pouya, et al.
Publicado: (2023)

Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics
por: Liu, Linsheng
Publicado: (2022)

Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
por: Chandrasekaran, Balakumar, et al.
Publicado: (2022)

Editorial: Ethnopharmacology of the lamiaceae: Opportunities and challenges for developing new medicines
por: Panda, Sujogya Kumar, et al.
Publicado: (2022)

Editorial: Pharmacogenetics and Pharmacogenomics in Latin America: Ethnic Variability, New Insights in Advances and Perspectives: A RELIVAF-CYTED Initiative
por: Esperón, Patricia, et al.
Publicado: (2022)

Editorial: Kampo Medicine in a Modern Context: Ethnopharmacological Perspectives
por: Kuchta, Kenny, et al.
Publicado: (2022)

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
por: Zhou, Fanfan, et al.
Publicado: (2022)

Editorial: Cancer therapy: The challenge of handling a double-edged sword
por: Nurgali, Kulmira, et al.
Publicado: (2022)

Editorial: Novel biomarkers for anticancer therapy
por: Wang, Ting, et al.
Publicado: (2023)

Editorial: New Advances in RNA Targeting
por: Ilinskaya, Olga, et al.
Publicado: (2020)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Editorial: Neuroinflammation and Its Resolution: From Molecular Mechanisms to Therapeutic Perspectives
por: Zusso, Morena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_er0k708bn8ap2megq19s7f33tt